Abstract:Tacrolimus, an inhibitor of the phosphatase calcineurin, is widely used as an immunosuppressive agent. However, its use is associated with hypertension and hyperkalemia. Although previous studies indicated that the activation of thiazide-sensitive, Na-Cl cotransporter (NCC) plays a key role in the pathogenesis, the identity of the direct target of calcineurin in kidney remained unclear. Kelch-like 3 (KLHL3) is a component of an E3 ubiquitin ligase that critically regulates NCC function. In pseudophyoaldoseronism type 2, the disease-causing mutations in KLHL3 impair binding and degradation of with-no-lysine 1 (WNK1) and WNK4, resulting in hypertension and hyperkalemia that are correctable by thiazide. Previously, we reported that phosphorylation of KLHL3 at serine 433 (KLHL3 S433-P ) by protein kinase C critically regulates KLHL3 function by abrogating the substrate-binding ability. However, phosphatases responsible for KLHL3 S433-P regulation were unknown. We here show that calcineurin acts as a phosphatase for KLHL3 S433-P . In in vitro phosphatase assay, we found that calcineurin suppressed KLHL3 S433-P levels (65% reduction from baseline). Consistently, the activation of calcineurin by ionomycin significantly reduced KLHL3 S433-P abundance in distal convoluted tubule cells and in HEK cells expressing KLHL3, an effect that was almost completely prevented by calcineurin knockdown. Moreover, we found that tacrolimus increased KLHL3 S433-P levels by 1.8 fold in mouse kidney, which was associated with the WNK accumulation and increased NCC activity. Finally, we found that tacrolimus attenuated KLHL3-mediated WNK4 ubiquitination and degradation, and this effect was abolished by non-phosphorylatable S433A substitution in KLHL3. These data identify Kelch-like 3 as a direct target of calcineurin, and provide evidence that KLHL3 is involved in the pathophysiology of tacrolimus-induced hypertension.

Protein Kinase-mediated Regulation of Calcineurin Through the Phosphorylation of Modulatory Calcineurin-interacting Protein 1

Calcineurin Enhances MAPK Phosphatase-1 Expression and p38 MAPK Inactivation in Cardiac Myocytes

Calcineurin Dephosphorylates Kelch-like 3, Reversing Phosphorylation by Angiotensin II and Regulating Renal Electrolyte Handling.

Transcriptional Upregulation of Calcineurin Aβ by Endothelin-1 is Partially Mediated by Calcium/calmodulin-Dependent Protein Kinase IIδ3 in Rat Cardiomyocytes

A13710 Calcineurin Dephosphorylates and Regulates the Ubiquitin Ligase Kelch-like 3

Usp16-Mediated Deubiquitination Of Calcineurin A Controls Peripheral T Cell Maintenance

CK1δ Kinase Activity is Modulated by Protein Kinase C Α (Pkcα)-Mediated Site-Specific Phosphorylation.

Calcineurin (PPP3CB) regulates angiotensin II-dependent vascular remodelling by potentiating EGFR signalling in mice

Abstract 068: Kelch-Like 3 Dephosphorylation by Calcineurin As a Mechanism Regulating Na-cl Cotransporter

P38α MAP Kinase Phosphorylates RCAN1 and Regulates Its Interaction with Calcineurin

Protein Phosphatase 2A Acts As a Mitogen-activated Protein Kinase Kinase Kinase 3 (MEKK3) Phosphatase to Inhibit Lysophosphatidic Acid-induced IκB Kinase Β/nuclear Factor-κB Activation

Calcineurin negatively regulates TLR-mediated activation pathways.

Catalytic subunits of the phosphatase calcineurin interact with NF-κB-inducing kinase (NIK) and attenuate NIK-dependent gene expression

Biochemical analyses reveal new insights into RCAN1/Rcn1 inhibition of calcineurin

Calcineurin Stimulates the Expression of Inflammatory Factors in RAW 264.7 Cells by Interacting with Proteasome Subunit Alpha Type 6.

Studies of Calcineurin B Subunit from Genetic Engineering for Use in Medicine

Mitogen-Activated Protein Kinase Phosphatase-1: A Critical Phosphatase Manipulating Mitogen-Activated Protein Kinase Signaling In Cardiovascular Disease

Structural Basis of Calcineurin Activation by Calmodulin

A New Family of Regulators of Calcineurin (Rcans)

Calcium/Calmodulin-Dependent Protein Kinase IV Mediates IFN-γ-Induced Immune Behaviors in Skeletal Muscle Cells

Mip1, an MEKK2-Interacting Protein, Controls MEKK2 Dimerization and Activation